What is the official website of Wobenzym ?

The official website of Wobenzym is https://www.wobenzym.de/.

What is Wobenzym's cybersecurity risk score?

Wobenzym has an AI-generated cybersecurity risk score of 770 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Wobenzym experienced?

According to Rankiteo, Wobenzym currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Wobenzym been affected by any supply chain cyber incidents ?

According to Rankiteo, Wobenzym has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Wobenzym have SOC 2 Type 1 certification ?

According to Rankiteo, Wobenzym is not certified under SOC 2 Type 1.

Does Wobenzym have SOC 2 Type 2 certification ?

According to Rankiteo, Wobenzym does not hold a SOC 2 Type 2 certification.

Does Wobenzym comply with GDPR ?

According to Rankiteo, Wobenzym is not listed as GDPR compliant.

Does Wobenzym have PCI DSS certification ?

According to Rankiteo, Wobenzym does not currently maintain PCI DSS compliance.

Does Wobenzym comply with HIPAA ?

According to Rankiteo, Wobenzym is not compliant with HIPAA regulations.

Does Wobenzym have ISO 27001 certification ?

According to Rankiteo,Wobenzym is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Wobenzym operate in ?

Wobenzym operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Wobenzym have ?

Wobenzym employs approximately None employees people worldwide.

Does Wobenzym own any subsidiaries ?

Wobenzym presently has no subsidiaries across any sectors.

How many LinkedIn followers does Wobenzym have ?

Wobenzym's official LinkedIn profile has approximately followers.

What is the NAICS classification code for Wobenzym ?

Wobenzym is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Wobenzym have a Crunchbase profile ?

No, Wobenzym does not have a profile on Crunchbase.

Does Wobenzym have a LinkedIn profile ?

Yes, Wobenzym maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/wobenzym.

How many cybersecurity incidents has Wobenzym experienced ?

As of June 13, 2026, Rankiteo reports that Wobenzym has not experienced any cybersecurity incidents.

How many peer or competitor companies does Wobenzym have ?

Wobenzym has an estimated 5,686 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Wobenzym

Boost Score +25 with badge (5 left)

770

/1000

Fair

795

/1000

Fair

Wobenzym Vendor Cyber Rating & Cyber Score

wobenzym.de

Add Your Compliance Badge

Das Arzneimittel Wobenzym kann die Heilung entzündlicher Verletzungen und Erkrankungen wie aktivierter Arthose, Venenentzündung oder Schwellungen nach Verletzung beschleunigen. Die in Wobenzym enthaltene Enzymkombination wirkt abschwellend und entzündungsregulierend, dadurch wirkt es ursächlich und unterdrückt nicht nur die Symptome. Pflichttext Deutschland: Wobenzym® magensaftresistente Tablette Anwendungsgebiete: Zur unterstützenden Behandlung von Erwachsenen bei Schwellungen, Entzündungen oder Schmerzen als Folge von Verletzungen, oberflächlicher Venenentzündung, Entzündung des Harn- und Geschlechtstrakts, schmerzhaften und aktivierten Arthrosen und Weichteilrheumatismus (Erkrankungsbild mit Beschwerden im Bereich von Muskeln, Sehnen,

Wobenzym A.I CyberSecurity Scoring

Scoring History

Wobenzym

Wobenzym CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Wobenzym Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Wobenzym

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Wobenzym in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Wobenzym in 2026.

Incident Types Wobenzym vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Wobenzym in 2026.

Incident History - Wobenzym (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Wobenzym Subsidiaries

Wobenzym

Pharmaceutical Manufacturing

Website: https://www.wobenzym.de/

Company Size: 51-200 employees

NestléFood and Beverage Services

Nestlé Nespresso SAFood and Beverage Services

Nespresso ProfessionalFood and Beverage Services

Nestlé ProfessionalFood and Beverage Services

Nestlé Purina North AmericaManufacturing

Nestlé IT North AmericaIT Services and IT Consulting

Purina Pro Plan Veterinary DietsConsumer Goods

Nestlé Research & DevelopmentGastronomie und Getränkeservice

GerberFood and Beverage Retail

Nestlé Purina PetCare EuropeConsumer Goods

Purina Pets At Work AllianceFood and Beverage Services

Cereal Partners Worldwide (Nestlé & General Mills)Food and Beverage Manufacturing

Nestlé Nutrition Engineering HubFood and Beverage Manufacturing

Gruppo SanpellegrinoServizi per la ristorazione

Tails.com | B CorpManufacturing

Nestlé Purina Petcare AustraliaConsumer Goods

UNLEASHED by PurinaFertigung

San Pellegrino DanmarkDetailsalg

Nestlé Purina PetCare Asia, Oceania and AfricaManufacturing

Nestlé Health ScienceFood and Beverage Manufacturing

VitafloHospitals and Health Care

Nestlé Health Science BrasilSaúde, bem-estar e educação física

Nestlé Health Science ItaliaSalute, benessere e fitness

Loading…

Wobenzym Similar Companies

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Novartis

cb novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Loading…

NEWS

Wobenzym CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-6676

SUMMARY

Heap buffer out-of-bounds write vulnerability in Avira Antivirus engine when scanning a malformed POSIX tar archive may allow Local Execution of Code or Denial-of-Service of the antivirus engine process. This issue affects Avira Antivirus on Windows, macOS, and Linux for engine builds before 8.3.27.12.

Published

Date2026-06-12

Updated

Date2026-06-12

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

https://www.gendigital.com/us/en/contact-us/security-advisories/

CVE-2026-12068

SUMMARY

Information disclosure vulnerability in Avira Password Manager when used with Mozilla Firefox may allow a remote attacker operating a cross-origin iframe to obtain credentials autofilled for the parent web page via incorrect autofill field selection. This issue affects Avira Password Manager when used with Mozilla Firefox on Windows, macOS, and Linux.

Published

Date2026-06-12

Updated

Date2026-06-12

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://www.gendigital.com/us/en/contact-us/security-advisories/

CVE-2025-9033

SUMMARY

Heap buffer out-of-bounds read vulnerability in Avira Antivirus engine when scanning a malformed PDF file may allow Local Execution of Code or Denial-of-Service of the antivirus engine process. This issue affects Avira Antivirus on Windows, macOS, and Linux for engine builds before 8.3.70.76.

Published

Date2026-06-12

Updated

Date2026-06-12

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

https://www.gendigital.com/us/en/contact-us/security-advisories/

CVE-2025-9032

SUMMARY

Heap buffer out-of-bounds read vulnerability in Avira Antivirus engine when scanning a malformed Windows PE file may allow Local Execution of Code or Denial-of-Service of the antivirus engine process. This issue affects Avira Antivirus on Windows, macOS, and Linux for engine builds before 8.3.70.98.

Published

Date2026-06-12

Updated

Date2026-06-12

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

https://www.gendigital.com/us/en/contact-us/security-advisories/

CVE-2025-14098

SUMMARY

Heap buffer out-of-bounds write vulnerability due to integer overflow in Avira Antivirus engine when scanning a malformed MS-DOS executable file may allow Local Execution of Code or Denial-of-Service of the antivirus engine process. This issue affects Avira Antivirus on Windows, macOS, and Linux for engine builds before 8.3.70.104.

Published

Date2026-06-12

Updated

Date2026-06-12

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

https://www.gendigital.com/us/en/contact-us/security-advisories/

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…